Sicel Technologies is pioneering a revolution in cancer therapy.
Founded in 1999, and headquartered in Morrisville, North Carolina, Sicel Technologies, Inc.,
is a privately held, specialty device company focused on the development of revolutionary
therapies for cancer treatment.
The company is developing revolutionary therapeutic systems that significantly impact the
treatment of cancer—a leading cause of death in the U.S., second only to heart disease.
For instance, traditional radiation therapy treatment options rely on knowing the exact
location of the tumor to be treated. While there are several methods available to
facilitate tumor localization, none provide actual dose information.
Sicel Technologies, Inc., has developed the first U.S. Food & Drug Administration-cleared
wireless implantable sensors and surface dosimetry radiation measurement devices that are
designed to assist clinicians in determining the actual dose of radiation being delivered
to the tumor. It is an unfortunate fact that even the slightest deviations in dose levels
delivered to the tumor site or radiation that is accidentally exposed to healthy tissue
surrounding the tumor, can have a profound impact on long-term survival rates and quality of
life for patients treated with radiation therapy.
|
OVERVIEW
BOARD
OF DIRECTORS